Phase I study of delivery of autologous bone marrow derived mononuclear cells to myopathic right ventricle in patients with Ebstein anomaly during surgical intervention
Grant Project Details:
The goal of this Phase I study is to establish the safety and feasibility of intramyocardial injection of autologous bone marrow derived mononuclear cells (BM-MNC) into the myopathic right ventricle of patients with Ebstein anomaly (EA) at time of elective cardiac surgery.
In no-cost extension to enroll additional patients in study
Grant Awardee Biography
Dr. Holst is a general and thoracic surgery resident at Mayo Clinic and a resident in the Clinician Investigator Training Program.